This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1991 Sep;165(3):779.

doi: 10.1016/0002-9378(91)90328-o.

Prognostic value of CA 125 and neopterin in women with ovarian cancer undergoing second-look laparotomy

L C Fuith, D Fuchs, G Reibnegger, H Wachter

PMID: 1892210
DOI: 10.1016/0002-9378(91)90328-o

Comment

Prognostic value of CA 125 and neopterin in women with ovarian cancer undergoing second-look laparotomy

L C Fuith et al. Am J Obstet Gynecol. 1991 Sep.

. 1991 Sep;165(3):779.

doi: 10.1016/0002-9378(91)90328-o.

Authors

L C Fuith, D Fuchs, G Reibnegger, H Wachter

PMID: 1892210
DOI: 10.1016/0002-9378(91)90328-o

No abstract available

PubMed Disclaimer

Comment on

The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction.
Hunter VJ, Daly L, Helms M, Soper JT, Berchuck A, Clarke-Pearson DL, Bast RC Jr. Hunter VJ, et al. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1164-7. doi: 10.1016/0002-9378(90)90680-6. Am J Obstet Gynecol. 1990. PMID: 2171337

Similar articles

The significance of neopterin determination as a tumour marker in ovarian cancer.
Szarka G, Pulay T, Csömör S, Tran-Phoung-Mai, Schumann B. Szarka G, et al. Acta Chir Hung. 1988;29(4):359-64. Acta Chir Hung. 1988. PMID: 3239335
CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.
Makar AP, Kristensen GB, Børmer OP, Tropé CG. Makar AP, et al. Gynecol Oncol. 1992 Jun;45(3):323-8. doi: 10.1016/0090-8258(92)90313-8. Gynecol Oncol. 1992. PMID: 1612511
The prognostic value of nuclear roundness and neopterin in ovarian cancer.
Marth C, Weger A, Müller-Holzner E, Zeimet AG, Moncayo-Naveda H, Daxenbichler G, Reibnegger G, Fuchs D, Wachter H, Dapunt O. Marth C, et al. Eur J Cancer. 1993;29A(13):1863-8. doi: 10.1016/0959-8049(93)90539-r. Eur J Cancer. 1993. PMID: 8260243
Second-look laparotomy in ovarian cancer.
Creasman WT. Creasman WT. Gynecol Oncol. 1994 Dec;55(3 Pt 2):S122-7. doi: 10.1006/gyno.1994.1350. Gynecol Oncol. 1994. PMID: 7835795 Review.
CA 125 in ovarian cancer.
van der Burg ME, Lammes FB, Verweij J. van der Burg ME, et al. Neth J Med. 1992 Feb;40(1-2):36-51. Neth J Med. 1992. PMID: 1579185 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program